Abstract | BACKGROUND: METHODS: RESULTS: Multivariate analysis showed that prognostic factors for lung adenocarcinoma were histologic type, CLDN1, T stage and N stage. Patients with positive CLDN1 expression had a poorer prognosis than patients with negative CLDN1 expression. CLDN1 expression was correlated with Ras and epidermal growth factor receptor (EGFR) expression. Patients with positive expressions of both CLDN1 and Ras/EGFR had a poorer prognosis than patients with CLDN1 (+) Ras/EGFR(-) or CLDN1 (-) Ras/EGFR(+) and patients with negative expressions of both CLDN1 and Ras/EGFR. CLDN1 mRNA expression was lower in the H358 compared with the lung adenocarcinoma cell line (A549). CONCLUSION: The combination of CLDN1 and Ras/EGFR is a valuable independent prognostic predictor for lung adenocarcinoma.
|
Authors | Bing-Sheng Sun, Yi-Qun Yao, Bao-Xiang Pei, Zhen-Fa Zhang, Chang-Li Wang |
Journal | Thoracic cancer
(Thorac Cancer)
Vol. 7
Issue 5
Pg. 556-563
(Sep 2016)
ISSN: 1759-7714 [Electronic] Singapore |
PMID | 27766775
(Publication Type: Journal Article)
|
Copyright | © 2016 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. |
Chemical References |
- CLDN1 protein, human
- Claudin-1
- EGFR protein, human
- ErbB Receptors
- ras Proteins
|
Topics |
- Adenocarcinoma
(genetics, metabolism, pathology)
- Adenocarcinoma of Lung
- Cell Line, Tumor
- Claudin-1
(genetics, metabolism)
- ErbB Receptors
(genetics)
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Lung Neoplasms
(genetics, metabolism, pathology)
- Male
- Neoplasm Staging
- Prognosis
- Tissue Array Analysis
(methods)
- Up-Regulation
- ras Proteins
(genetics)
|